Sattva S. Neelapu, MD: Encouraging Results for CAR T-Cells in Refractory DLBCL
1,481 views · Published 7 December 2016 · 6:21 · Indexed 22 October 2026
Channel: American Society of Hematology · 2016 · Nonprofits & Activism
Dr. Neelapu shares results from the ZUMA-1 trial, in which treatment with anti-CD19 CAR T-cell therapy led to complete remissions in patients with relapsed diffuse large B-cell lymphoma.
More from this channel
-
1:52
Ron Reagan Accepts ASH Award - Stem Cell Research
-
4:25
Sen. Jim Talent's Work on Sickle Cell Disease Legislation
-
3:56
ASH and the Reagans Support Stem Cell Research
-
5:42
The American Society of Hematology Celebrates its 50th Anniversary
-
5:57
David Nathan Receives 2011 Wallace H. Coulter Award for Lifetime Achievement in Hematology
-
5:17
James George Receives 2012 Wallace H. Coulter Award for Lifetime Achievement in Hematology
-
2:21
Congress: Protect NIH funding
-
2:21
Act Now: Tell Congress to Stop Further Cuts to Research Funding